Sapio Sciences and Ultima Genomics Partner for Seamless, Scalable Multi-Omics Solutions

Strategic Insights -

Baltimore-based Sapio Sciences and Ultima Genomics have joined forces to revolutionize multi-omics research and clinical genomics. The strategic partnership combines Sapio's AI-powered lab informatics solutions with Ultima's cutting-edge, high-throughput sequencing platform, providing researchers with efficient, traceable, and unified workflows. This collaboration aims to make multi-omics research more accessible and cost-effective, enabling deeper levels of analysis and understanding of complex biology.

Key Takeaways:

  • Sapio Sciences and Ultima Genomics have formed a strategic partnership to integrate their respective technologies, creating a seamless and scalable solution for multi-omics research and clinical genomics.
  • The partnership combines Sapio's AI-powered lab informatics platform with Ultima's ultra-high throughput sequencing architecture, designed to drive down sequencing costs and scale beyond conventional technologies.
  • Ultima Genomics' multi-omics sequencing capabilities allow researchers to study layers of biology beyond DNA sequences alone, making it an essential tool for understanding complex biology.
  • Sapio Sciences' analytics, automation, and data management tools will be integrated with Ultima Genomics' sequencing data generation capabilities to provide a unified, end-to-end solution.
  • Partnering companies will enable researchers and clinicians to accelerate discovery, drive AI-powered insights, and bring high-quality genomics into everyday workflows with unmatched efficiency and traceability.
  • Gilad Almogy, CEO and founder of Ultima Genomics, emphasized the importance of the partnership in enabling leading sequencing labs and making genomic information more scalable.

Statistics:

  • Ultima Genomics' ultra-high throughput sequencing architecture is designed to drive down sequencing costs and scale beyond conventional technologies.
  • Sapio Sciences' AI-powered lab informatics platform will be integrated with Ultima Genomics' sequencing data generation capabilities, providing a seamless and unified solution.
  • The partnership will enable multiple costly assays and fragmented workflows to be replaced with an efficient, end-to-end solution.
  • Ultima Genomics' multi-omics sequencing capabilities will allow researchers to study layers of biology beyond DNA sequences alone, improving understanding of complex biology.

Sources:

  • Ultima Genomics:

+ "Partnering with Sapio Sciences aligns with our goals to enable leading sequencing labs and make genomic information more scalable."

+ "By integrating our high-throughput, low-cost sequencing platform with Sapio's AI-powered lab informatics platform, we're enabling a seamless, scalable solution for multi-omics research and clinical genomics." (Gilad Almogy, CEO and founder of Ultima Genomics)

  • Sapio Sciences: The science-awareTM lab informatics platform (not dated).